ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Clinton Seeks Cut In NIH Increase

May 27, 1994

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

May 17, 1991

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

In Brief: INTRA-NCI Scramble For Funds involves “Tricks, Machinations, Day To Day Battle”

July 16, 1976